China SXT Pharmaceuticals, Inc. announced that its DNA Exam Laboratory completely built in October of 2019 recently has been approved by Jiangsu province Drug Administration (JSDA). The Laboratory has been granted to perform research and development (R&D) and quality control of TCM raw materials and TCMP products applying DNA testing technology. The DNA testing technology can be extensively used for developing new TCMP products, analyzing and examining in accordance with highly specific standard of TCMP raw materials, and their products, especially, the Advanced TCMPs. The new application of the DNA testing technology would significantly enhance the Company's R&D and the quality control capabilities, in particular for the TCMP products which regulations require achieving certain explicit standard.